BRECCIA, M.; ALIMENA, G. SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs. Mediterranean Journal of Hematology and Infectious Diseases, v. 6, n. 1, p. e2014003, 2 jan. 2014.